Literature DB >> 19445021

Post-surgical irradiation causes cellular immune suppression in patients with breast cancer.

G V Koukourakis1, H Zabatis, G A Zacharias, M J Koukourakis.   

Abstract

According to several studies, even the locoregional irradiation of patients with carcinoma can cause a severe and rather alarming cellular immune defect. We thus designed a prospective research in order to study the effect of post-operative irradiation on cellular immunity in patients suffering from breast cancer. In 35 patients with breast cancer who required post-operative irradiation, four blood samples were taken at indicated point times. Nineteen out of 35 patients received post-surgical chemotherapy before irradiation. The total lymphocytes as well as CD4 and CD8 subpopulations were measured by using flow cytometry analysis. The mean T-lymphocyte (Tol) count dropped from 1487.77 to 1227.91 (P = 0.0013) and the CD4+ count from 674.17 to 580.91 (P = 0.0189). The mean value of CD8+ dropped from 421.31 to 314.00 (P = 0.0003). Moreover, a statistically significant difference regarding the pattern of temporal change was observed between a group of patients that received irradiation only and a group that received radiation therapy (RT) with chemotherapy (P-values 0.0015, 0.01 and 0.092 for Tol, CD4+ and CD8+ respectively). The group of patients that received RT only presented a more rapid decrease of Tol concerning the decrease observed in the group that underwent chemotherapy and RT.

Entities:  

Mesh:

Year:  2009        PMID: 19445021     DOI: 10.1111/j.1365-2354.2008.00995.x

Source DB:  PubMed          Journal:  Eur J Cancer Care (Engl)        ISSN: 0961-5423            Impact factor:   2.520


  3 in total

1.  CD4+ memory T cells retain surface expression of CD31 independently of thymic function in patients with lymphoproliferative disorders following autologous hematopoietic stem-cell transplantation.

Authors:  Egor V Batorov; Marina A Tikhonova; Irina V Kryuchkova; Vera V Sergeevicheva; Svetlana A Sizikova; Galina Y Ushakova; Dariya S Batorova; Andrey V Gilevich; Alexander A Ostanin; Ekaterina Y Shevela; Elena R Chernykh
Journal:  Int J Hematol       Date:  2017-03-14       Impact factor: 2.490

2.  Baseline immune biomarkers as predictors of MBSR(BC) treatment success in off-treatment breast cancer patients.

Authors:  Richard R Reich; Cecile A Lengacher; Kevin E Kip; Steven C Shivers; Michael J Schell; Melissa M Shelton; Raymond H Widen; Catherine Newton; Michelle K Barta; Carly L Paterson; Jerrica R Farias; Charles E Cox; Thomas W Klein
Journal:  Biol Res Nurs       Date:  2014-01-28       Impact factor: 2.522

3.  Impact of partial versus whole breast radiation therapy on fatigue, perceived stress, quality of life and natural killer cell activity in women with breast cancer.

Authors:  Kevin Albuquerque; Dina Tell; Philip Lobo; Linda Millbrandt; Herbert L Mathews; Linda Witek Janusek
Journal:  BMC Cancer       Date:  2012-06-18       Impact factor: 4.430

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.